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ABSTRACT  
 
Introduction 
 
Hereditary Epidermolysis bullosa (EB) is a group of rare mechanobullous  
dermatological disorders in which blisters develop following gene mutations. These 
genes encode structural proteins that anchor the epidermis to the underlying dermis. 
There are four main types of Epidermolysis bullosa, with more than 20 subtypes. The 
medical, physical and psychosocial aspects of Epidermolysis bullosa are well 
documented (Lucky et al, 2005; Mellerio et al, 2005). Many studies have documented 
case reports of associated oral lesions (Silva et al, 2004; Pacheco and de Sousa Araugio 
2008; Siqueira et al, 2008). However, no assessment of the impact of these oral lesions 
on the affected person's everyday life has been made. The morbidity of the oral lesions 
associated with EB is expected to have an impact on the quality of life of these patients. 
 
Aim 
To assess the prevalence and impact of oral lesions on daily activities in persons with 
Epidermolysis bullosa in Cape Town, South Africa, utilizing the Oral Impact on Daily 
Performance (OIDP) measure. 
 
Research Design and Methodology 
A case-controlled, descriptive analysis of the way in which oral lesions impact on quality 
of life in persons with Epidermolysis bullosa was carried out using semi-structured 
interviews. Fourteen persons with a confirmed diagnosis of hereditary Epidermolysis 
bullosa who attended the dermatology clinics at the Red Cross and Groote Schuur 
hospitals participated in the study. The control group comprised eighteen persons closely 
matched for gender, age, and dental status.  Three persons with EB were unavailable for 
inclusion in the study. 
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Results and Discussion 
Fourteen persons with Epidermolysis bullosa and eighteen controls were included in the 
study. Epidermolysis bullosa Simplex comprised the largest sub-group (n=9). Two 
persons had Junctional Epidermolysis bullosa, two had recessive Dystrophic 
Epidermolysis bullosa and one person had Kindler syndrome. 
 
The oral manifestations observed were consistent with those reported in the literature 
(Chimenos et al, 2003; Silva et al, 2004; Pekinar et al, 2005). No significant oral 
lesions (other than tooth decay) were seen in persons in the Epidermolysis bullosa 
Simplex group. Oral ulcers, atrophy of the dorsal surface of the tongue and gingival 
erythema were seen in persons with Junctional Epidermolysis Bullosa. The two 
individuals with Dystrophic Epidermolysis bullosa had a maximal oral opening of 15mm 
and 24mm. Ankyloglossia, depapillation of the dorsal tongue, absence of palatal rugae 
and poor oral hygiene was seen in these two persons. The patient with Kindler syndrome 
presented with erythematous and inflamed gingiva and cratering in the maxillary anterior 
interdental area. The gingiva appeared desquamative, fragile and bled with even the 
slightest provocation. Healing peri-oral blisters and angular cheilitis was also seen. His 
mouth opening was restricted to a maximal oral aperture of 13mm and his tongue 
extrusion was limited to only the tip of the tongue passing over the lower anterior incisor 
teeth. 
 
Defects in the tooth enamel was recorded in both participants with Junctional 
Epidermolysis bullosa and one person with dystrophic Epidermolysis bullosa, as well as 
excessive occlussal tooth wear (attrition), which may have been secondary to enamel 
hypoplasia. The dental caries status of the Epidermolysis bullosa and control groups 
varied according to age. The dmf for persons with Epidermolysis bullosa (all of whom 
had Epidermolysis bullosa Simplex), was lower than in the control group. The DMF in 
EB persons (15.3) was higher than in the control group (10.1). 
 
Toothache and tooth decay were the most common perceived complaints in both the 
Epidermolysis bullosa and control participants, accounting for the high overall OIDP 
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score in both groups (87.5%). No statistically significant difference was found between 
the two groups (85.7% and 88.9% for Epidermolysis bullosa and control group persons 
respectively).  
 
Conclusion 
The results of the study show that oral lesions (particularly tooth decay and toothache) in 
persons with Epidermolysis bullosa do affect their daily activities and the impact thereof 
is high. Other oral manifestations, irrespective of the subtype, had little impact on the 
OIDP score. This may be because the EB persons become tolerant of and “learn to cope” 
with them.  
 
Recommendations 
Epidermolysis bullosa is a rare condition and not all persons with EB will present with 
lesions. However, all health personnel (including oral health profession) must be 
cognizant of this condition, in order to manage these persons safely, without incurring 
harm inadvertently. Thus, the overall management of persons with Epidermolysis bullosa 
must encompass ways to minimize and prevent trauma; provide an optimum wound 
healing environment; provide pain management and judicious checks for the 
development of premalignant lesions. This necessitates a multidisciplinary and holistic 
approach, with emphasis on patient involvement. To this end, an oral health care 
programme should form an integral part of their management because of the risk of 
dental disease. Periodic recall visits will enable the monitoring of home care and 
minimize the need for advanced restorative procedures. In this way, one may reduce the 
impact any oral problems may have, so that they do not further influence the patients well 
being.  
 
Keywords 
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CHAPTER 1: INTRODUCTION 
1.1. Structure of the report 
 
For the benefit of the reader, this text will outline the format of this report describing the 
oral manifestations seen in fourteen persons with Epidermolysis bullosa and how they 
perceive these lesions to affect their daily activities. This mini-thesis comprises five 
chapters, describing the various aspects investigated. Chapter 1 summarizes the 
background and purpose for the study. Chapter 2 details the literature review, including a 
concise overview of the most recent classification of Epidermolysis bullosa types and 
subtypes; salient clinical features associated with the various forms of EB as well as 
diagnostic techniques used. A summary of international case reports is included, 
documenting the type and prevalence of oral lesions reported in the various 
Epidermolysis bullosa types. Lastly, a summary of the quality of life assessment tool 
(OIDP) used in the study is presented.  
 
Chapter 3 lists the study aim and objectives. Chapter 4 discusses the research design and 
methodology used, describing the research tool and data collection method. Chapter 5, 
Chapter 6 and Chapter 7 detail the study results, discussion and conclusion respectively.  
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1.2.Background and purpose of the study 
Hereditary Epidermolysis bullosa (EB) is a group of rare mechanobullous  
dermatological disorders, with an autosomal dominant or recessive mode of transmission. 
Blisters develop following mutation of genes, which encode structural proteins within the 
epidermis, or those that anchor the epidermis to the underlying dermis.  Four main types 
exist with more than 20 subtypes, each distinguished based on their clinical 
manifestations, inheritance pattern, ultra- structural findings and implicated gene(s) (Fine 
et al, 2008). The target pathology may be supra-basal (Epidermolysis bullosa Simplex); 
at the junction between the dermis and the epidermis (Junctional Epidermolysis bullosa); 
sub-basal (Dystrophic Epidermolysis bullosa); or have mixed cleavage planes (Kindler 
syndrome) (Pekinar et al, 2007; Fine et al, 1989; 2008). 
 
Clinically, Epidermolysis bullosa is characterized by skin fragility and diverse variability 
exists within the phenotypic spectrum of the condition (Mellerio et al, 2007). Blisters 
arise most commonly following minor trauma or spontaneously (Winship, 1986; 
Pfender et al, 2005). The clinical features range from mild blisters localized to the hands 
and feet, to severe generalized mucocutaneous blistering (Pekinar et al, 2007; Pfender 
et al, 2007). Dystrophic Epidermolysis bullosa is often associated with significant 
scarring which can cause relative microstomia due to oral contractures. 
  
The medical, physical and psychosocial aspects of Epidermolysis bullosa are well 
documented (Fine et al, 2008; Van Scheppingen et al, 2008). Oral lesions may have an 
impact on the quality of life of patients, as well as their nutritional status.  The integral 
role of interdisciplinary care in attaining a good quality of life for the affected persons, 
cannot be overemphasized (Lucky, et al 2005). Many international studies have 
documented case reports of oral lesions associated with Epidermolysis bullosa subtypes 
(Silva et al, 2004; Pacheco and Araugio 2008; Siqueira et al, 2008) however, the 
impact of these oral lesions in everyday life of the affected persons has not been assessed. 
The subtypes of EB in South African families have been delineated and published as part 
of a doctoral thesis (Winship, 1986), but no record of their oral status has been reported. 
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Slade and Spencer in 1997 (Sanders et al, 2006), developed an assessment tool named 
the Oral Impact on Daily Performance (OIDP), which was designed to measure the 
impact of socio-dental factors on daily activities. It would complement the normative 
clinical measures and allow a broader assessment of the way in which oral changes 
impact on patients’ quality of life. The value of employing such a tool allows one to 
associate the impact to specific oral lesions that require attention, potentially provide 
more insight into consequences of untreated oral lesions and highlight the benefits of 
dental treatment.  
 
 
 
 
 18
CHAPTER 2: LITERATURE REVIEW 
 
Many advances with regard to the spectrum and classification of inherited Epidermolysis 
bullosa have been made and most recently, a Consensus Classification group redefined 
the heritable Epidermolysis bullosa types and subtypes. These include: Epidermolysis 
bullosa Simplex; Junctional Epidermolysis bullosa; Dystrophic Epidermolysis bullosa 
and Kindler syndrome (Fine et al, 2008).  
 
2.1. DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 
The clinical diagnosis of Epidermolysis bullosa in a neonate or mildly affected adult is 
challenging for the following reasons (Uitto and Richard, 2005). 
1. it mimics other vesiculobullous conditions  
2. the initial generalized blistering may later resolve into a more localized 
Epidermolysis bullosa subtype (inverse type in particular) 
3. some newborns with severe generalized manifestations, may manifest as a milder 
localized Epidermolysis bullosa type later on 
 
A biopsy of clinically unaffected skin is mandatory for a diagnosis of EB. The level of 
tissue separation correlates with the affected epidermal protein components and is 
subtype dependant. Currently two laboratory techniques are employed to identify the 
cleavage plane within the skin of suspected Epidermolysis bullosa persons. These include 
transmission electron microscopy and immunofluorescence mapping.  A third diagnostic 
technique (DNA mutational analysis) is reserved for prenatal diagnosis (Pfender et al, 
2005). 
 
2.1.1. Transmission Electron Microscopy (TEM) – (Mihai and Sitaru, 2007) 
The main advantage of electron microscopy (EM) is that it allows visualization of 
specific proteins within the skin. There are differences in the number or appearance of  
specific proteins in the various subtypes of Epidermolysis bullosa. These structures 
include desmosomes, keratin filaments, hemi-desmosomes, sub-basal dense plates, 
anchoring filaments and anchoring fibrils. This technique however, does not allow 
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assessment of alterations in antigenicity, because for assessment by EM, the tissue must 
be fixed in gluteraldehyde. The proteins involved in anchoring the epidermis to the 
underlying dermis have discreet locations and an additional procedure called antigenic 
immunofluorescence mapping allows assessment of the location of the protein (i.e. either 
within the roof or base of the blister). 
  
EM is extremely technique sensitive and can be misleading if performed by 
inexperienced clinicians and laboratories (Fine et al, 2008). It is however, the only non-
molecular laboratory technique that can identify persons with Dowling Meara 
Epidermolysis bullosa Simplex, a rare subtype (Uitto and Richard, 2005). 
 
2.1.2. Immunofluorescence Mapping (IFM) 
IFM is diagnostically as reliable as EM for some of the Epidermolysis bullosa subtypes. 
Specimens harvested from fresh spontaneous or traction induced blisters are transported 
in specific IFM transport media. The cryo-preserved skin specimens are exposed to a 
panel of antibodies (such as bullous pemphigoid antigen, laminin-1, type IV collagen and 
keratin 14). In addition, monoclonal and polyclonal antibodies to laminin-332 (formerly 
laminin-5), type VII collagen, type XVII collagen, plectin, α6β4 integrin and keratin 14 
may be applied to Epidermolysis bullosa skin sections to elucidate alterations in their 
relative expression and distribution within the skin. The degree of antibody staining is 
semi-quantitative and cannot be exclusively used to distinguish between the 
Epidermolysis bullosa subtypes within a tissue specimen. Thus, its use should be reserved 
as a primary laboratory marker for diagnosis of suspected Epidermolysis bullosa persons 
and used prior to mutational analysis (Fine et al, 2008). 
 
IFM has the following advantages over EM: 
1. It is less expensive and simpler to perform 
2. The tissues can be processed within a few hours and the specific transport media 
preserves tissue antigenicity for several weeks at a given temperature. 
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2.1.3.  DNA Mutational analysis 
DNA mutational analysis is the most accurate method in determining the mode of 
inheritance as well as the exact location and type of inherent molecular mutation. Future 
gene therapy will be dependant hereon. IFM should be the primary laboratory marker for 
diagnosis because there are too many possible genes that need to be screened before 
identifying where the ultrastructural defect lies (epidermis, lamina lucida, or sub-lamina 
densa). In addition, not all the “mutational hotspots” have been identified for every 
Epidermolysis bullosa type or subtype. Identification of these sites will require entire 
gene sequencing to determine the mutation and more than one gene may be implicated in 
the same phenotype. In addition, the fact that not all mutations have been identified in 
every Epidermolysis bullosa patient, suggests the presence of unidentified genes. Lastly, 
genotype-phenotype correlation is only predictable in  the Epidermolysis bullosa Simplex 
type.  In addition to all the points mentioned above, DNA testing is expensive and 
technique sensitive, with very few capable laboratories available worldwide (Fine et al, 
2008). Even though DNA testing is the most accurate diagnostic tool currently available, 
it is reserved solely for prenatal diagnosis of Epidermolysis bullosa, once the family 
proband has been identified (Fine, 2008). 
 
2.2. CLASSIFICATION OF EPIDERMOLYSIS BULLOSA 
Epidermolysis bullosa is classified into 4 major types: Epidermolysis bullosa Simplex; 
Junctional Epidermolysis bullosa, Dystrophic Epidermolysis bullosa and Kindler 
syndrome (Pfender et al, 2005; Fine et al, 2008).  
  
The four main types of Epidermolysis bullosa are tabulated below (Table 1). There 
classification is based on: 
i. the level of tissue separation  
ii. the inheritance pattern and clinical severity 
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Table 1:  Inherited E pidermolysis Bullosa Types and Subtypes  
Epidermolysis 
bullosa type 
Inheritance 
Pattern 
Epidermolysis 
bullosa 
subtype 
Target protein 
(gene) 
Ultrastructural 
site of epidermal 
tissue separation
Epidermolysis 
bullosa 
Simplex 
Autosomal 
dominant 
Suprabasal PKP1 (plakophilin-
1) 
DSP (desmoplakin) 
Intra-epidermal, 
within basal 
keratinocytes 
Autosomal 
recessive – 
(X linked) 
Basal KRT5 (Keratin-5) 
KRT14 (Keratin 
14) 
PLEC1 (plectin) 
ITGA6, ITGB4 
(α6β4 integrin) 
Junctional 
Epidermolysis 
bullosa 
Autosomal 
recessive 
Herlitz LAMA3, LAMB3, 
LAMC2 (laminin-
332) 
Within the lamina 
lucida of 
basement 
membrane  Non-Herlitz 
(Other) 
LAMA3, LAMB3, 
LAMC2,  
COL17A1 (TYPE 
XVII collagen) 
ITGA6, ITGB4 
(α6β4 integrin) 
Dystrophic 
Epidermolysis 
bullosa 
Autosomal 
recessive 
 
Dominant COL7A1 (type VII 
collagen) 
Below lamina 
densa 
Recessive COL7A1 (type VII 
collagen) 
Kindler 
Syndrome 
Autosomal 
recessive 
 
 KIND1  
(kindling-1) 
Mixed cleavage 
plane 
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For the purpose of this report, reference will be made to the most common Epidermolysis 
bullosa subtypes (Epidermolysis bullosa Simplex localized, Epidermolysis bullosa 
simplex generalized; Dowling-Meara Epidermolysis bullosa simplex; Herlitz and non-
Herlitz Junctional Epidermolysis bullosa; dominant Dystrophic Epidermolysis bullosa 
and recessive Dystrophic Epidermolysis bullosa and Kindler syndrome). For further 
information, the reader is referred to the thesis delineating Epidermolysis bullosa types in 
South Africa (Winship, 1986). 
 
2.2.1. EPIDERMOLYSIS BULLOSA SIMPLEX  
Epidermolysis bullosa Simplex (EBS) is the most common type and denoted as the non-
scarring form of the condition. Epidermolysis bullosa Simplex is subdivided into supra-
basal and basal forms (Fine et al, 2008) and is tabulated in Table 2. Ammendments to the 
classification scheme included the replacement of the Weber Cockayne and Koebner 
subtypes by localized Epidermolysis bullosa Simplex and Epidermolysis bullosa Simplex 
generalized respectively. 
Mode of inheritance 
Epidermolysis bullosa Simplex is usually inherited as autosomal dominant condition, but 
an autosomal recessive inheritance has been described in some cases (Pfender et al, 
2005).  
Mutation in the genes KRT5 or KRT 14, which encode for keratins 5 and 14 are 
responsible for the dominantly inherited phenotypes of EBS. The skin of the affected 
person breaks easily because the mutant proteins (keratins) make the inside skeleton of 
skin cells weak. Blisters arise following separation within the basal keratinocytes and 
range from mild and localized (in Epidermolysis bullosa Simplex, localized), to mild 
generalized (in Epidermolysis bullosa Simplex, generalized), to severe (as seen in the 
Dowling-Meara subtype)(Pfender et al, 2005). The clinical severity is related to the 
exact location of point mutations within these keratin polypeptides. 
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Clinical features (Gorlin et al, 2001)  
Localized Epidermolysis bullosa Simplex (previously termed Weber-Cockayne subtype), 
manifests with blisters in friction-exposed sites such as hands and feet. This form of EB 
is diagnosed in children younger than one year. Despite its limitation to the epidermis and 
areas of friction, the potential for all skin surfaces to be involved exists because the 
mutation is inherent within every keratinocyte. Blister formation is exacerbated during 
the summer months. 
Epidermolysis bullosa Simplex superficialis is characterized by blisters, milia, healing 
with atrophic scarring, nail dystrophy, oral and conjunctival involvement. The oral cavity 
and corneal surface are the most common extracutaneous sites. 
Generalized blistering occurs in Epidermolysis bullosa Simplex generalized and the 
Dowling-Meara herpetiformis subtype. In the former, blisters arise not only in response 
to friction or trauma, but also due to a predisposition to heat. Unlike the localized variant, 
these blisters are evident from birth, or during the first few weeks of life. The involved 
sites include the feet, hands and neck, with infrequent extra-cutaneous involvement. 
Lesions do not heal with scarring or pigmentation and generally improves by puberty. 
Occasional intra-oral blister formation occurs, with no associated tooth alterations, but 
not as prominently as in the more severe subtypes. 
The Dowling-Meara herpetiformis subtype may be evident at birth or within the first 
three months, manifesting with widespread blistering, erythema and skin loss. A hoarse 
cry is characteristic and the characteristic herpetiform bullae arrangement may only 
become evident later in life. These serous hemorrhagic blisters occur on any part of the 
body, especially the palms, soles, peri-oral regions, trunk and neck. Lesions usually heal 
without scarring but a concomitant intense inflammatory reaction within the hemorrhagic 
blisters is elicited. Associated milia and pigmentary alterations of the skin are reported. 
The skin lesions improve during periods of fever, in the summer months, and with 
advancing age. The clinical picture is equally variable within and between families. 
 
 
 
 
 24
 
Epidermolysis bullosa Simplex with muscular dystrophy (Epidermolysis bullosa simplex-
MD) has an autosomal recessive inheritance pattern and is the most severe Epidermolysis 
bullosa Simplex subtype (Gorlin et al 2001, Uitto and Richard, 2005). Its onset is 
evident at birth, manifesting with erythema, widespread blistering, erosions and denuded 
skin. These features become more widespread and severe with increasing age involving 
the extremities, with frequent oral and other mucosal involvement. Other sequential 
features include palmoplantar keratoderma, nail dystrophy, milia, pigmentary changes 
and secondary infections. Healing by mild atrophic scarring occurs in most persons. 
Mutations in the plectin gene implicated in Epidermolysis bullosa simplex-MD could 
account for the skin fragility and muscular weakness seen in these persons. Its 
hypothesized that plectin plays a role in muscle facilitating binding of actin to membrane 
complexes.  
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Table 2: Revised Epidermolysis bullosa Simplex (EBS) Classification   
 
Major 
Epidermolysis 
bullosa 
Simplex types 
Epidermolysis bullosa Simplex subtypes Target proteins 
Suprabasal Lethal acantholytic epidermolysis bullosa 
Plakophilin deficiency 
Epidermolysis bullosas superficialis (E BSS)
Desmoplakin 
Plakophilin 
? 
Basal Epidermolysis bullosa simplex, localized 
(EBS-LOC) * 
Epidermolysis bullosa simplex Dowling 
Meara (EBS-DM) 
Epidermolysis bullosa simplex , other 
generalized (EBS, gen- nonDM) # 
Epidermolysis bullosa simplex with mottled 
pigmentation (EBS-MP) 
Epidermolysis bullosa simplex with 
muscular dystrophy (EBS-MD) 
Epidermolysis bullosa simplex with pyloric 
atresia (EBS-PA) 
Epidermolysis bullosa simplex, autosomal 
recessive (EBS-AR) 
Epidermolysis bullosa simplex, Ogna (EBS-
Og) 
Epidermolysis bullosa simplex migratory 
circinate (EBS-migr) 
K5, K14 
 
K5, K14 
 
K5, K14 
 
K5 
 
Plectin 
 
Plectin,α6β4 integrin 
 
K14 
 
Plectin 
 
K5 
*Epidermolysis bullosa simplex, localized was previously denoted Weber-Cockayne 
#Epidermolysis bullosa simplex generalized includes patients previously classified as 
Epidermolysis bullosa simplex Koebner subtype.  
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2.2.2. JUNCTIONAL EPIDERMOLYSIS BULLOSA (JEB) 
 
Junctional Epidermolysis bullosa is divided into 2 major and several minor groups based 
on clinical severity (Fine et al, 2008). The two major variants include Herlitz and non-
Herlitz types and the distinction is based upon disease severity. In the Herlitz subtype, the 
pathology occurs at the level of the lamina lucida. In the non-Herlitz subtype, blister 
formation occurs within the basement membrane zone at the hemi-desmosomal or the 
basal cell/lamina lucida interface. In general, mild blistering occurs in the non-Herlitz 
variant and the Herlitz sub-type manifests with a more severe phenotype, with persons 
generally not surviving beyond infancy (Uitto and Richard, 2005). 
 
Mode of transmission 
Junctional Epidermolysis bullosa has an almost exclusively autosomal recessive form of 
inheritance, with mutations in four genes encoding the affected proteins. These include 
subunits of laminin 332 complex: alpha 3 (LAMA 3); beta-3 (LAMB3) and gamma-2 
(LAMC2). Laminins are essential components of anchoring filaments in the basement 
membrane zone. In addition, mutations of Type XVII collagen and α6β4 integrin are 
associated with non-Herlitz forms such as Junctional Epidermolysis bullosa with pyloric 
atresia). 
 
Clinical features 
The non-Herlitz Junctional Epidermolysis bullosa is subdivided into 2 distinct groups 
(Table 3) – Junctional Epidermolysis bullosa non-Herlitz generalized and localized. In 
this subtype, affected persons survive infancy and live a normal lifespan, with the disease 
process slowing with age. Junctional Epidermolysis bullosa non-Herlitz generalized is 
characterized by blister formation in addition to extra-cutaneous manifestations: 
fingernail dystrophy, focal scarring alopecia of the scalp, loss of eyelashes, dental 
anomalies (enamel hypoplasia, pitting of the enamel) and patchy macular 
hyperpigmentation (Uitto and Richard, 2005). The same clinical features occur in 
Junctional Epidermolysis bullosa Herlitz subtype, but with increased severity. Clinically, 
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phenotypic variations occur within families and the condition is non-lethal, with no 
genotype/phenotype correlation. 
 
The Herlitz junctional Epidermolysis bullosa subtype has more severe manifestations, 
often with fatal consequences, being mostly due to respiratory failure and sepsis. Persons 
with Herlitz junctional Epidermolysis bullosa have hemidesmosomal hypoplasia with a 
mild decrease in tonofibrils. This form exhibits exuberant granulation tissue formation 
following erosions and blister formation, most notably around or within body orifices 
(peri-oral, perinasal, intranasal and infraocular), axilla, uppermost back and posterior 
neck (Pfender et al, 2005; Fine et al, 2008).  Blisters involve the entire skin surface and 
multiple organ involvement is common. Oral involvement is common and will be 
discussed in Section 2.3. 
 
Anemia, growth retardation and gingiva-laryngeal strictures are common to both 
Junctional Epidermolysis bullosa subtypes. 
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Table 3: Junctional Epidermolysis bullosa subtypes 
Major Junctional 
Epidermolysis bullosa 
type 
Subtype Targeted protein 
Junctional 
Epidermolysis bullosa,  
Herlitz (JEB-H) 
 Laminin 332 
Junctional 
Epidermolysis bullosa 
other  
(JEB-O) 
 Junctional Epidermolysis bullosa, 
non-Herlitz generalized (JEB-
nHgen) # 
Laminin 332, type 
XVII collagen 
  Junctional Epidermolysis bullosa, 
non-Herlitz localized (JEB-Nh loc) 
Type XVII collagen 
Junctional Epidermolysis bullosa  
with pyloric atresia (JE B-PA) 
α6β4 integrin 
Junctional Epidermolysis bullosa, 
inverse (JEB-I) 
Laminin 332 
Junctional Epidermolysis bullosa, 
late onset (JEB-lo) + 
? 
LOC Syndrome Laminin 332 
 
# Junctional Epidermolysis bullosa, non-Herlitz generalized is formerly known as 
generalized atrophic benign (GAB Epidermolysis bullosa)  
+ Junctional Epidermolysis bullosa late onset was formerly known as junctional 
Epidermolysis bullosa progressive 
 
2.2.3. DYSTROPHIC EPIDERMOLYSIS BULLOSA  
Persons with Dystrophic Epidermolysis bullosa exhibit a broad range of phenotypes. This 
variant is generally associated with extensive scarring because of the biologic location of 
the defect and blistering is induced by minimal friction (Pfender et al, 2005).  
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Mode of transmission 
Dystrophic Epidermolysis bullosa may have either an autosomal dominant or recessive 
inheritance pattern. In Dystrophic Epidermolysis bullosa, mutations occur in COL7AI 
gene that encodes type VII collagen. The latter forms the predominant component of  the 
anchoring fibrils that connect the basement membrane to the underlying dermis. 
Mutations in the gene, located at 3q21.1 results in an abnormal morphology, reduction or 
complete absence of these anchoring fibrils at the dermal-epidermal junction (Pfender et 
al, 2005; Uitto and Richard, 2005; Azrak et al, 2006). In addition, the mutation also 
results in increased collagen disintegration within the superficial dermis due to excess 
collagenase synthesis. 
 
Clinical manifestations 
Clinically Dystrophic Epidermolysis bullosa lesions range from mild (in the dominant 
variant) to severe and mutilating (in the autosomal recessive Hallopeau-Siemens 
subtype). In the milder form, blistering of the skin and mucous membranes forms in 
response to mechanical force, due to a shortage of anchoring fibrils in the sub-basal 
lamina region. Clinically flat, pink, scar-producing bullae are seen on the ankles, knees, 
hands, elbows and feet, in decreasing order or frequency. Milia occur less commonly than 
with the recessive variants and the nails are usually thick and dystrophic. The cornea and 
conjunctiva are never involved, unlike recessive dystrophic cases. About 20% of persons 
manifest clinical changes before the age of 1 year and lesions generally improve with age 
(Fine et al, 1989 and 2008). 
 
The autosomal recessive Dystrophic Epidermolysis bullosa subtype (RDEBg or the 
Hallopeau-Siemens variant) involves all extremities, joints and mucosal surfaces, with 
eye and oral involvement being most common. Bullae usually arise at or shortly after 
birth, at sites predisposed to minor pressure, trauma or even spontaneously. Initially the 
fluid contained within the bullae is sterile, but it may become secondarily infected and 
haemorrhagic. Ruptured bullae reveal a raw painful surface and healing elicits keloidal 
disfiguring scars and skin contractures as well as continuous morbid fibrous adhesions of 
the mucosa (Horn and Tidman, 2002; Fine et al, 2008).  
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The metacarpals become slender, overconstricted and distal phalanges become pointed 
and claw-like.  Scarring of the hand leads to mitten deformities, pseudosyndactaly, 
dystrophy and contractures and nails are often absent or dystrophic (Gorlin et al, 2001).  
 
Mucosal involvement can eventually cause complications involving the oesophagus, 
intestinal and urinary tracts. The upper half of the oesophagus may become sequentially 
stenotic in childhood, with subsequent dysphagia. The resultant nutritional difficulties 
retard growth with subsequent shortened life spans. Anemia is a common presentation 
due to bleeding from the denuded areas. 
 
Squamous cell carcinomas are common and by the age of 25 and 35 years, 23.7% and 
51%, patients with Hallopeau-Siemens variants have developed at least one squamous 
cell carcinoma. In addition, the cumulative risk of malignant melanoma was reported as 
being 4.1% by age 12 years. 
 
Little increased risk of death occurs in recessive Dystrophic Epidermolysis bullosa 
patients until after the age of 20. By age 40, however the risk of death is 33.3% 
coinciding with the timing of consequent reports of squamous cell carcinomas in this 
patient population. 
 
A rare and less severe variant of autosomal recessive dystrophic Epidermolysis bullosa is 
RDEB inverse. It is clinically characterized by lesions located in flexural areas of the 
body sparing the fingers and toes, but without the severe generalized blistering, growth 
retardation and digital webbing characteristic of Hallopeau-Siemens dystrophic 
Epidermolyis bullosa variant. Oral involvement is similar to, but milder than the 
Hallopeau-Siemens subtype. These include ankyloglossia, loss of tongue papillae, and 
obliteration of the oral vestibule between the lips and gingival, with apparently normal 
teeth (Wright et al, 1993).  
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Table 4: Major Dystrophic Epidermolysis bullosa types 
Dystrophic 
Epidermolysis 
bullosa types 
Subtypes Targeted 
protein 
Dystrophic EB Dystrophic Epidermolysis bullosa, generalized 
(DEB-gen) 
Type VII 
collagen 
Dystrophic Epidermolysis bullosa, acral (DEB-ac) 
Dystrophic Epidermolysis bullosa, pretibial (DEB-
Pt) 
Dystrophic Epidermolysis  pruriginosa (DEB-Pr) 
Dystrophic Epidermolysis bullosa, nails only 
(DEB-na) 
Dystrophic Epidermolysis bullosa, bullous 
dermolysis of the newborn (DEB-BDN) 
Recessive 
dystrophic EB 
Recessive Epidermolysis bullosa, severe 
generalized (RDEB-sev gen) 
Type VII 
collagen 
 Recessive Epidermolysis bullosa, generalized 
other (RDEB-O) 
Recessive Epidermolysis bullosa, generalized 
other, inverse (RDEB-I) 
Recessive Epidermolysis bullosa, generalized 
other Recessive dystrophic Epidermolysis bullosa 
pretibial (RDEB-Pt) 
Recessive dystrophic Epidermolysis bullosa 
pruriginosa (RDEB-Pr) 
Recessive Epidermolysis bullosa, generalized, 
centripitalis (RDEB-Ce) 
Recessive Epidermolysis bullosa, generalized, 
bullous dermolysis of the newborn (RDEB-BDN) 
RDEB, severe generalized was previously known as RDEB, Hallopeau-Siemens. 
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2.2.4. KINDLER SYNDROME 
 
Kindler syndrome is and autosomal recessive genodermatosis characterized by trauma-
induced blistering, poikiloderma, skin atrophy, mucosal inflammation and 
photosensitivity (Lai-Cheong et al, 2009). Despite the inclusion of Kindler syndrome as 
a fourth subtype in the revised Epidermolysis bullosa classification system (Fine et al, 
2008), it has distinct clinical, pathologic and molecular abnormalities.  
 
In Kindler syndrome, desmosomal and hemidesmosomal mutations are not implicated. A 
defect or deficiency in the focal adhesion protein (fermitin family homologue), results in 
an abnormality of the association between the actin cytoskeleton of the extracellular 
matrix. Clinically it resembles Dystrophic Epidermolysis bullosa and congenital 
poikiloderma, but features diversify with increasing age.   Congenital poikiloderma is an 
inherited autosomal recessive syndrome seen chiefly in women. Manifestations include 
reticular, atrophic, hyperpigmented and telangiectatic cutaneous plaques, often with 
associated juvenile cataracts, a saddle nose, congenital bone defects, hypogonadism, with 
differential growth of hair, nails and teeth (Chimenos et al, 2003; Lai-Cheong et al, 
2009). 
 
Clinical features of Kindler syndrome 
The clinical features of this syndrome include blistering of trauma-exposed sites, 
progressive poikiloderma, atrophy of the skin on the dorsum of the hands and feet and 
photosensitivity. Both the blistering and photosensitivity becomes less evident with age. 
Early-onset periodontal disease and severe desquamative gingivitis causes bleeding gums 
and tooth loss. Mucosal involvement leads to anal, vaginal, urethral and oesophageal 
stenosis. Gastro-intestinal tract involvement manifests with bloody gingiva and severe 
colitis, while finger webbing, pseudosyndactaly, squamous cell carcinoma and nail 
dystrophy are also reported (Chimenos et al, 2003). 
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Diagnosis of KS 
The genetic defect is unknown and ultrastructural analysis via TEM is often non-specific, 
with variability in affected persons. The purported ultrastructural defects are numerous. 
Some studies have suggested a defect in the adhesion molecules anchoring the basal cell 
layer to the lamina densa, others noted  vacuolization of the basal layer and epidermal 
atrophy (cited in Wiebe et al, 2008), multiple cleavage planes, prominent reduplication 
of the lamina densa, with cleft development in regions following destruction of the 
lamina densa. Anchoring fibrils and hemidesmosomes may still be intact. Electron 
microscopy of blistered KS skin reveals cleft formation within the basal keratinocytes, 
below the lamina densa, or within the lamina lucida. In addition, tonofilament clumping 
is evident in keratinocytes next to blistered areas – similar to some Epidermolysis bullosa 
cases.  Two pathognomonic features of Kindler syndrome includes: reduplication of 
lamina densa and disorganization of basal cell layer. Features of other poikilodermas are 
also consistently found within such biopsies. These include melanin incontinence (seen 
within the dermis), along with the presence of melanophages, colloid bodies and ectasia 
of blood vessels. In addition, collagen lysis with disruption of elastic tissues may be seen. 
 
Ultrastructural analysis is location dependant, with cleavage planes close to the dermal-
epidermal junction in a skin biopsy from a blistered area.  A skin biopsy of an area with 
poikiloderma exhibits hyperkeratosis and epidermal atrophy with loss of rete ridges.    
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2.3. ORAL MANIFESTATIONS OF EPIDERMOLYSIS BULLOSA 
 
Oral manifestations of Epidermolysis bullosa are variable, ranging from small vesicles to 
large bullae that rupture to reveal a denuded surface (Travis et al, 1992). Such severe 
dental and gingival anomalies occur commonly in persons with recessive Dystrophic 
Epidermolysis bullosa (Silva et al, 2004). These occur on virtually any intra-oral surface 
and may be present at birth due to the intra-uterine activity of fetal sucking in persons 
with recessive dystrophic Epidermolysis bullosa (Azrak et al, 2006). Table 5 summarizes 
the oral findings documented in case reports of persons with Epidermolysis bullosa 
(Tomlinson, 1983; Serrano-Martinez et al, 2003; Silva et al, 2004; Azrak et al, 2006; 
Pekinar et al, 2007;  Pacheco et al, 2008; Siqueira et al , 2008).  
 
2.3.1. Oral manifestations in Epidermolysis bullosa Simplex (Gorlin et al, 2001) 
There is a paucity of information regarding oral manifestations seen in the Epidermolysis 
bullosa Simplex type. Some authors have reported on increased caries susceptibility in 
hypoplastic enamel, delayed eruption, frequent retention, with little information regarding 
lesion frequency. There is consensus that no correlation exists between the cutaneous 
involvement and degree of dental involvement. Histologic studies of unerupted teeth 
published by Delaire and colleagues and Arwill and co-workers noted enamel hypoplasia 
with absence of prismatic structures. Examination of extracted teeth showed an 
accentuation of enamel tuft formation extending from the dentino-enamel junction to the 
enamel surface. Irregular dentinal gingiva and indentations were at the dentino-enamel 
junction. 
 
Oral mucosal involvement can occur in both the localized and generalized Epidermolysis 
bullosa simplex subtypes. These blisters generally do not pose a problem during feeding 
except in the Dowling-Meara herpetiformis subtype. Some infants with this subtype can 
manifest with severe blistering of the mouth and oesophagus, making it difficult for the 
baby to feed. The application of teething gels prior to feeding as well as moistening of the 
teat with cooled boiled water before feeding will prevent the dry teat sticking to the 
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blistered areas. In addition moistening the lips with petroleum jelly can prevent further 
damage. 
  
2.3.2. Oral manifestations in Junctional Epidermolysis bullosa (Almaani et al, 
2008).: 
Oral lesions vary according to the subtype. Bullae and chronic erosions are found in 
nearly all patients especially at the junction of the hard and soft palates. These bullae are 
remarkably fragile and hemorrhagic. Oral ulcers and blisters are seen at birth or shortly 
thereafter. Enamel hypoplasia and pitting of the molars occurs. Enamel formation is 
abnormal, leading to extensive caries. Histological studies of soft tissue lesions show 
cleavage between the epithelium and the connective tissue. Peri-oral and peri-nasal 
crusted and granular hemorrhagic lesions tend to develop between the sixth and twelfth 
months of life. These lesions are considered pathognomonic for the Herlitz type of 
Epidermolysis bullosa in older patients. 
 
2.3.2 Oral manifestations associated with Dystrophic Epidermolysis bullosa 
 
The most prevalent oral mucosal involvement is seen in recessive Dystrophic 
Epidermolysis bullosa with generalized involvement (Serrano-Martinez et al, 2003; 
Abercrombie et al, 2008). These include blisters, malformed teeth, hypoplastic enamel 
and extensive dental caries. Repeated vesicles, bullae and erosions result in scar 
formation, which consequential intra-oral alterations: atrophy of tongue papillae and 
palatal folds; obliteration of the gingival vestibule and frenum; tonsillar pillar fusion, 
ankyloglossia and microstomia.  
 
The extensive dental caries seen in these persons is hypothesized to be due to a soft diet 
rich in carbohydrates. The soft tissue blistering and associated discomfort is responsible 
for this limited diet. In addition, reduced oral clearance because of limited tongue 
mobility and vestibular constriction may also play a role, but no evidence of reduced 
salivary function was found. 
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In dystrophic Epidermolysis bullosa, bullous eruptions form after trauma and heal leaving 
atrophic scars and milia. These are epidermoid cysts originating from detached islands of 
epithelium in sites of previous bullae and appear as small white nodules beneath the 
scars.  Teeth are generally unaffected and whilst a 20% prevalence of oral bullae has been 
reported, however the samples have been small.  
 
Oral mucosal blisters can occur at any intra-oral site and contain either sterile fluid or 
blood, with the lingual mucosa being the most frequent location, followed by the soft and 
hard palate (Serrano-Martinez et al, 2003). They are painful and heal by fibrosis. The 
mucosa and attached gingiva is smooth, erythematous and oedematous. Fetal sucking in 
the uterus can elicit blisters that are noticeable at birth. The consequential healing and 
scarring will over time result in microstomia (decreased oral aperture); tongue atrophy 
and lingual depapillation; ankyloglossia; atrophy of the palatal folds; gingival ridge 
obliteration, tonsillar pillar fusion, ankyloglossia and microstomia. Dysfunction of the 
opening of the pharynx may result in stricture of the air passage and digestive system. 
Thus maintaining their dentition not only reduces the risk of oral and oesophageal 
mucosal trauma, but also results in improved nutrition (Penarrocha et al, 2007). During 
blister formation and cicatrization, milium cysts develop due to entrapment of epithelial 
cells (Serrano-Martinez et al, 2003). This occurs often in the hard palate. 
 
 A reduced enamel mineral content was reported in severe forms of Dystrophic 
Epidermolysis bullosa, but developmental enamel defects were only reported in 8.6% of 
persons in this prevalence study (Wright, 1993). Caries is quite prevalent because of the 
reduced oral hygiene and consumption of soft foods (Azrak et al, 2006). 
 
Wright and Fine, 1994 reported areas of leukoplakia and oral squamous cell carcinoma of 
the lingual mucosa, suggested being due to repeated ulceration and re-epithelialization 
and periodic assessment is recommended for recessive Dystrophic Epidermolysis bullosa 
persons (Serrano-Martinez et al, 2003). 
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2.3.3 Oral Manifestations of Kindler Syndrome 
Few reports of Kindler Syndrome as well as its management are documented in the 
literature. Oral findings such as gingivitis, bleeding gums, mucosal erosions, atrophy, 
white patches, periodontal disease (Wiebe et al, 2008), lip pigmentation and limited 
mouth opening have been reported. The latter is due to sclerosis at the commissures of 
the mouth following healing of bulla and resultant scar formation (Rickets et al, 1997). 
 
Desquamative gingivitis seen may resemble that seen in other vesiculobullous conditions 
such as pemphigus, lichen planus or pemphigoid. In Kindler syndrome, the marginal 
gingiva is desquamative, inflamed and erythematous because of increased susceptibility 
to inflammation induced by bacterial plaque in this fragile gingival.  Inadequate oral 
hygiene is a common finding due to a combination of oral discomfort and reduced 
dexterity. To this end, regular oral hygiene maintenance visits for scaling and polishing 
has shown to significantly improve both the gingival condition as well as patient comfort 
(Wiebe et al, 2008).  
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2.4. ORAL HEALTH-RELATED QUALITY OF LIFE MEASURES (OHRQoL)  
 
“The extension of people’s lifespans and the enhancement of their quality of life” form 
pivotal goals of health-care systems (Slade et al, 1998). There has been a concerted 
paradigm shift with regard to the perception and evaluation of oral health. Oral health 
does not only imply being disease free, but also an improvement in the quality of health 
(Allen, 2007).   Previous oral health assessment involved the measurement of disease, by 
virtue of various clinical indices (Guyatt et al, 1993). These measures however focus on 
disease outcome, only reflecting the end- point of disease, with no indication as to the 
patient’s perspective on how it affects their daily functioning (Allen, 2003). Implicit 
herein is that while clinical indicators are vital for oral disease measurement, when used 
alone, proves inadequate for a true oral health assessment and formulation of treatment 
needs. This assessment must measure how oral conditions interfere with everyday life 
and if they alter normal conduct such as inability to go to work or school. 
 
The term oral health related quality of life (OHR-QOL) is defined as “a broad conception 
of health, encompassing the traditional definition of health, but also including 
individuals’ subjective impact of health on well-being and functioning in every-day life”  
(cited in Allen, 2007). In 1989,   Locker provided the impetus for a more “holistic” 
model of health measurement based on the WHO classification of impairment, 
disabilities and handicap (Allen, 2003).  Implicit in this model is that disease, health and 
quality of life be separately defined. This became apparent in studies of chronic 
conditions who reported a good quality of life, despite severe physical limitations (Allen, 
2007). Thus, health and quality of life are both theoretically and philosophically distinct 
concepts and in addition, so too are measures of health status and those assessing oral 
health-related quality of life are distinct (Allen, 2007). In a critical review of such 
measures, two researchers highlighted criteria, which must be met for measures used to 
assess “health related quality of life”, but others felt that their criteria were too rigorous 
and suggested a more liberal approach. Despite their differences, it was concluded that 
two pertinent issues, common to both approaches, must be considered when evaluating 
such measures. Firstly, the measure must represent patients’ perspectives and concerns 
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rather than those of medical practitioners. Secondly, these measures must integrate 
everyday- life activities important to the target group (Allen, 2007).   
 
Various instruments for the assessment of oral-health related quality of life (OHRQoL) 
measures have evolved and been described and explored in studies (Allen, 2003 and 
2007). These include the Geriatric/General Oral Health Index of Assessment (GOHAI); 
Oral Health Impact Profile (OHIP); Oral Impacts on Daily Performance (OIDP) and the 
Child Oral Health Quality of Life Questionnaires. Locker and Allen, (2007), critically 
appraised the validity and reliability of these OHRQoL measures and compared them to 
the ideal characteristics of oral-health related quality of life measure, as developed by 
Adulyanon and Sheiham, 1997. They concluded that the Geriatric/General Oral Health 
Index of Assessment (GOHIA) measure met too few requirements and was best reserved 
for subjective assessment of oral health status. While the OHIP assesses self-perceived 
oral health and measure the social impact of oral disorders, its disadvantage was that, the 
measures were “expert-centered”, designed to fit a theoretical framework rather than 
reflect the importance to the persons from whom they were obtained. The Oral Impacts 
on Daily Performances measure was unique in that its design enabled assessment of the 
population’s dental needs, in collaboration with conventional measures. Secondly, it is 
the “gold standard” measurement for assessing “behavioural” effects of oral disorders 
and the degree to which the ability to perform physical, psychological and social 
performances is compromised”. Despite the fact that it appears to be the most “expert-
centred” measure, it has the most compound item scoring system. It assesses both impact 
frequency and severity (Bernabe et al, 2007), such that multiplying these parameters 
gives one specific performance scores (highlighting specific dental conditions that 
resulted in the impact). Adding the scores gives one a total impact score. Linking the 
specific oral problem to the impact may be useful in assessing dental health needs as well 
as prioritizing dental health care services – ensuring that the problem associated with the 
impact receives treatment (Gherupong et al, 2004). 
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Oral health related quality of life 
Epidermolysis bullosa is a chronic condition for which there is no curative therapy. 
Treatment is palliative and is aimed at improving patient comfort. The medical and 
psychological aspects of Epidermolysis bullosa are well documented. Thus, the rationale 
for assessing oral impacts in this population is warranted, because oral disease does affect 
eating, smiling and socializing. OHRQoL measures have largely been used to assess 
impacts in population-based settings, with limited exposure in specific patient based 
cohorts (Bernabe et al, 2007). The nature of reports on oral manifestations in persons 
with Epidermolysis bullosa is largely case reports and the need to assess the sensitivity of 
an OHRQoL measure such an OIDP was investigated.  
 
Oral Impact on Daily Performance (OIDP) Tool: 
The oral impact on daily performance measure (OIDP) is the most widely used quality of 
life assessment socio-dental indicator. The conceptual framework is based upon the 
WHO’s International Classification of Impairments, Disabilities and Handicaps. The 
OIDP has been suitably modified to encompass varying degrees of the concept: oral 
status or impairments, intermediate impacts (pain, discomfort, functional limitation or 
dissatisfaction with appearance), and ultimate impacts which cover the concepts of 
disability and handicap. The concept of the (OIDP) focuses on the third measurement 
level by assessing the frequency, severity and extent to which oral disease impact on the 
participants’ ability to fulfill eight daily tasks. These include eating and enjoyment 
thereof; speaking and  clear  pronunciation; cleaning teeth; sleeping and relaxation; 
smiling, laughing and showing teeth without fear of embarrassment; maintaining one’s 
emotional state without becoming irritable; the ability to perform usual work or social 
role and enjoying contact with others. 
 
Frequency and severity estimates in all participants are calculated using five point scales. 
The responses to the frequency impact ranges from 0 (not affected in the past six months) 
to 5 (everyday or nearly everyday for the past 6 months). Impact severity scores are rated 
by participants on a scale of 0 (no effect) to 5 (severe). Each performance score is 
calculated by multiplying the frequency and severity scores extracted from the relevant 
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questions. The overall performance score involves addition of each performance score, as 
described below: 
 
Performance score = Frequency score*Severity score  
(E.g. Eating score = Eating Frequency*Eating Severity) 
 
OIDP score = [(eating frequency*eating severity) + (speaking frequency*speaking 
severity) + (cleaning frequency*cleaning severity) + (sleeping frequency*sleeping 
severity) + (smiling frequency*smiling severity) + (emotional frequency*emotional 
severity) + (work/schoolwork frequency*work/schoolwork severity) + (social contact 
frequency*social contact severity)]*100/200  
  
The OIDP is validated for use in both adults and children between the ages of 11-12 year 
old (Tsakos et al, 2001; Bernabe et al, 2007;).  The use of the OIDP in children younger 
than 11 years old was adapted for the present study. A systematic review undertaken to 
determine the correlation between parents’ and their childrens’ rating of “ill-health” on 
the children’s lives (Barbosa, 2007), concluded that the parent’s responses were 
considered representative. 
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CHAPTER 3: METHODOLOGY 
 
3.1. AIM 
To assess the prevalence and impact of oral lesions on daily activities (OIDP) in persons 
with Epidermolysis bullosa in Cape Town, South Africa. 
 
3.2. OBJECTIVES 
 
1. To determine the prevalence of oral mucosal lesions  
2. To determine the dental caries experience (DMF and dmf) 
3. To assess the impact of frequency, severity and extent (number of affected daily 
activities) of oral lesions on daily activities 
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CHAPTER 4: RESEARCH DESIGN AND METHODOLOGY 
 
 
This chapter discusses the research design and methodology used in the study and 
describes the research tool and data collection method. 
 
4.1. Study Design 
This present study is a case-controlled, descriptive analysis of the way in which perceived 
oral lesions impact on the quality of life in persons with Epidermolysis bullosa. The latter 
was assessed by conducting face-to-face interviews using a structured questionnaire.  
 
4.2. Selection of study population 
The study population consisted of fourteen persons with a confirmed diagnosis of 
hereditary Epidermolysis bullosa attending the dermatology clinics at the Red Cross and 
Groote Schuur hospitals and 18 persons loosely matched for age, gender, socio-economic 
and dental status (control group). Three Epidermolysis bullosa persons were not available 
for evaluation. The chosen sites were dedicated clinics where persons with Epidermolysis 
bullosa presented for regular follow-up visits. Social status amongst the participants 
considered “equal” as both Epidermolysis bullosa and control persons utilized the public 
health facilities. The participants were divided into three groups: “toddlers”(< 5years of 
age); “older children”(5 -14 years) and “adults”(15 years and older). 
 
4.3. Study population and sampling 
The sampling of the participants from the clinics was by means of a convenience sample 
of all available Epidermolysis bullosa persons attending the Red Cross Children’s 
hospital and Groote Schuur dermatology clinics, with a loosely matched control group of 
persons attending the same dermatology clinics. 
  
4.3.1. Inclusion criteria 
Persons with Epidermolysis bullosa 
• Persons with a confirmed diagnosis of Epidermolysis bullosa 
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• All ages 
• Fully informed , written consent obtained  
• Permission obtained for clinical photography and for publication of data and 
photographs. 
Control Group 
• Persons loosely matched for age; dental status (primary dentition; mixed 
dentition; secondary dentition); attending the dermatology clinic at the 
aforementioned hospitals 
• Fully informed, written consent obtained 
• Permission obtained for clinical photography and for publication of data and 
photographs 
 
4.4 Ethical approval 
Ethical approval was obtained from the University of the Western Cape Dental Faculty 
and The University of Cape Town Ethical Review Board. Individual patient consent for 
the clinical oral examination and the face-to-face interview responses were recorded on 
the questionnaire.  Participants were free to withdraw from the study at any stage and 
assured that this would not affect any referral for treatment. Participants received 
information about their oral health status following the examination. 
 
4.5. Data Collection 
The parameters assessed included demographic measurements; presence of oral lesions; 
dental caries index (dmf and DMF)*; gingival inflammation (GI); plaque status (PI) and 
OHRQoL data. 
* As described in the World Health Organization Oral Health Survey Manual (1997) 
 
1.Demographic data 
This included age at last birthday; gender; occupational status and reason for attending 
the dermatology clinic.  
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2. Oral  lesions 
The presence of oral and peri-oral lesions was recorded on data capturing sheets. 
 
3.Dental caries index 
The dental caries index measured the dental caries experience of the participants. The 
indices used were DMF and dmf (Klein et al, 1938 in WHO, 1997). 
 
3.i. DMF index measured the condition of the permanent teeth: 
D =decayed teeth 
M =missing teeth (due to caries) 
F = filled teeth (with amalgam and or composite material) 
 
Procedure 
Each tooth in the mouth was examined using set criteria and teeth are classified as 
decayed, missing, filled or sound. The sum of decayed, missing and filled gave the 
individual DMF. 
  
3.ii. dmf 
This index is applicable to children identify primary teeth in children 5 years and under 
and is recorded similarly to DMF for permanent teeth: 
d = decayed teeth 
m = missing teeth 
f = filled teeth 
 
Each tooth in the mouth was examined using set criteria and teeth are classified as 
decayed, missing, filled or sound. The sum of decayed, missing and filled gave the 
individual dmf. 
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4. Plaque Index (Silness and Löe, 1964 – in Katzenellenbogen et al, 1997) 
The plaque index (PI) assessed the amount of plaque present at the gingival area. The 
selected teeth were examined on four gingival areas (distal, mesial, facial and lingual). 
Each area was assigned a score from 0-3.  
The plaque index was scored as follows: 
Score 0 :  No plaque 
Score 1 :   A film of plaque adhering to the free gingival margin and adjacent area 
  of the tooth. The plaque is visible after application of disclosing solution 
  or by using the probe on the tooth surface 
Score 2 : Moderate accumulation of soft deposits within the gingival pocket, or on 
the tooth and gingival margin, which can be seen with the naked eye. 
Score 3: Abundance of soft matter within the gingival pocket and/or on the tooth 
and gingival margin. 
 
5. Gingival Index (Löe and Silness, 1963 – in Katzenellenbogen et al, 1997) 
The Gingival Index (GI) assessed the degree of gingival inflammation present in the 
distal, mesial, facial and lingual areas. Each area was assigned a score from 0-3. 
The Gingival Index was recorded as follows: 
Score 0: Absence of inflammation  
Score 1: Mild inflammation; slight change in colour and little change in texture. 
Score 2: Moderate inflammation; moderate glazing; redness; edema and 
hypertrophy; bleeding on pressure 
Score 3: Severe inflammation; marked redness and hypertrophy; tendency towards 
spontaneous bleeding 
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6. Oral Impacts on Daily Performance (OIDP) 
 
OHRQoL was assessed via a structured individual interview approach that recorded 
OIDP data in addition to two global self-report indicators (perceived general and oral 
health problems and perceived oral treatment need). 
  
 The use of global health oral ratings have been extensively employed and found to 
correlate with functional impairment and well-being (Robinson et al, 2001).Participants 
were asked to rate their general health and perceived satisfaction with their mouth (oral 
health) on a scale of 0 (poor) to 5 (excellent). Due to the small sample size, variables for 
the perception of general and dental health were collated into two groups: “poor or fair” 
(scores 1-2) and “good, very good, excellent” (scores 3-5). The perceived need for dental 
treatment was categorized into “no-not much need” (scores of 1-2) and “need” (scores of 
3-5). All interviews were conducted by the principle researcher. 
 
4.5. Data analysis 
Simple frequency counts of oral lesions were captured in Microsoft Excel® and analyzed 
with the same package. The more complex statistical calculations were performed using 
Number Cruncher Statistical System (NCSS ®). Data for the OIDP tool was obtained 
from the questionnaires. The data was coded and entered into the computer and analyzed 
based on the points assigned to each question. This was to determine associations 
between perceived oral conditions and its impact on eight daily activities in the 
participants. Non-parametric tests were used due to a lack of normality (standard 
statistical distribution) and the small sample sizes involved. The Kruskal –Wallis non-
parametric test compared the Medians (location) of several independent groups.  
 
Various graphical methods were used to display the results obtained from the data 
collection, such as Pie charts, Violin plots as well as Box plots. The violin plot is a 
density plot showing the relative concentrations of observations of a univariate 
measurement, which enables the reader to distinguish more than one mode if present. A 
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Box plot does not have the ability to identify the presence of more than one mode in an 
empirical distribution. 
 
 
 
 
 51
CHAPTER 5: RESULTS 
 
5.1 Introduction 
 
This section details the findings of this study. Participants provided demographic 
information regarding their age, sex and occupational status. Records pertaining to their 
Epidermolysis diagnosis, reason for visiting the dermatology clinic (in control group) and 
medicaments used were obtained from the participants’ medical files. Face-to-face 
individual interviews were used to obtain the data relating to global oral health rating and 
the OIDP tool. 
  
5.2 Demography of the study population 
Thirty-two participants (32) were included in the study and comprised fourteen 
Epidermolysis bullosa (14) and eighteen control persons (18), loosely matched for 
gender, age, socio-economic and dental status. 
 
1. Gender distribution 
Half the sample was female with an equal distribution in both the Epidermolysis bullosa 
(8) and control group (8). There were ten and six males in the control and Epidermolysis 
bullosa groups respectively. 
 
2. Age range 
The age distribution of the sample (Table 6) was broad and ranged from 1 to 55 years in 
the control group and from 2 to 53 years in the Epidermolysis bullosa group.  
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 Table 6: Age and gender distribution in Epidermolysis bullosa and control 
participants  
Data Control Epidermolysis bullosa 
 Female Male Female Male 
Total sample 
number 8 10 8 6 
Average age in 
years 20.25 20.20 21.88 19.00 
Standard 
Deviation 13.25 19.33 17.31 14.25 
Min of age in 
years 1 2 2 3 
Max of age in 
years 36 55 53 36 
 
3. Occupational status 
The occupational status of the two groups was similar (Table 7), except that the two 
unemployed persons with Epidermolysis bullosa received disability grants as a source of 
income. 
  
Table 7: Occupational status of sample 
 Epidermolysis bullosa (14)  Control (18) 
Pre-school 3 3 
Scholar 5 7 
Unemployed 2 2 
Employed 4 6 
 
 
4. Reason for attending the dermatology clinic (Figure 1) 
Epidermolysis bullosa Simplex (Figure 2) was the most common type, seen in 9 of the 
fourteen Epidermolysis bullosa participants. Two persons had Junctional EB , two others 
had Dystrophic EB (Figures 3,4)  and one person had Kindler syndrome (Figure 5).  
 
Amongst the control participants, most children presented for eczema and asthma related 
problems (Table 8). The adults in the control group had a broad range of presentations, 
ranging from seborrheic keratosis to erythema multiforme and basal cell carcinoma.  
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Figure 1: Epidermolysis bullosa types present in the sample 
 
 
Table 8: Reason for attending the dermatology clinic in control participants 
 Gender
Female Male 
Swollen adenoids - 1 
Asthma 1 1 
Basal cell carcinoma - 1 
Control 1 - 
Eczema  - 4 
Erythema multiforme  - 1 
HIV skin lesions 2 - 
Psoriasis 1 1 
Seborrheic keratosis  - 1 
Squamous papillomas  1 - 
Other 2 - 
Total 8 10 
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Figure 2 
Atrophy and hypopigmentation following healing of peri-oral blisters in boy with 
Epidermolysis bullosa Simplex 
 
 
 
       
       Figure 3 
Skin blisters in person with Dystrophic Epidermolysis bullosa
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Figure 4 
Flexion contractures of right hand with severe atrophic scarring of skin in person 
with Dystrophic Epidermolysis bullosa 
 
 
Figure 5 
Poikiloderma of the skin and healing peri-oral blisters seen in Kindler syndrome 
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5. General and dental health questions (Global oral health ratings score) 
There were no statistically significant differences with regard to general and dental health 
questions between the Epidermolysis bullosa and control persons. In fact, all participants 
with Epidermolysis bullosa (14) rated their general health as “good, very good and 
excellent” whereas two persons in the control group perceived their general health as 
“poor or fair”.  
 
The distribution for the Epidermolysis bullosa and control persons was similar with 
regard to the perception of their dental health. “Good, very good and excellent” dental 
health perception was slightly higher (53.1%) than those persons who perceived their 
dental health as “poor and fair” (46.9%).  
 
A greater need for dental treatment was expressed overall by participants in both groups 
(62.5%) compared to those who felt they had “no – very little need” (37.5%). 
 
Twenty-two participants (68.8%) reported that they received advice on how to care for 
their mouth, with an equal distribution between the Epidermolysis bullosa (10) and 
control groups (12). The advice on how to care for their mouth was received mostly from 
dental health personnel. 
 
6. Oral lesions in persons with Epidermolysis bullosa 
No significant oral lesions (other than tooth decay) were seen in persons in the 
Epidermolysis bullosa Simplex group. Oral lesions were present in persons with 
Junctional Epidermolysis bullosa, Dystrophic Epidermolysis bullosa and Kindler 
syndrome (Table 9). 
  
A 4mm wide zone of bright gingival erythema was seen in the maxillary anterior region, 
extending from the marginal to the attached gingival, in only one person with Junctional 
Epidermolysis bullosa (Figure 6). The lesion did not appear to be plaque related despite 
her high plaque and gingival indices. Oral ulceration of the soft palate was seen in one  
JEB patient (Figure 7). The other ulcer was seen on the attached gingival above the first 
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right premolar. Both ulcers were small (<5mm), well circumscribed, with a white base 
and surrounded by an erythematous halo. Even though no oral ulcers were seen in the 
other Junctional Epidermolysis bullosa participant, its incidence was reported to be quite 
common especially in relation to eating “harder” foods such as toast. Depapillation of the 
dorsal surface of the tongue (Figure 8) was seen in the same participant as well as thick, 
ropey saliva. Both JEB individuals had enamel defects with wear of the occlussal tooth 
surfaces (Figure 9). 
 
Of the two individuals with recessive dystrophic Epidermolysis bullosa, both were 
female, in the same age range and had a maximal oral opening was 15mm and 24mm 
respectively (Figure 10). The patient with the most severe microstomia also had 
ankyloglossia, depapillation of the dorsal tongue, absence of palatal rugae (Figure 11) 
and predominantly roots remnants in her mouth (Figure 12), with poor oral hygiene. The 
second recessive dystrophic Epidermolysis bullosa female person exhibited severely 
worn down teeth covered by excessive amounts of plaque, and gingivae that bled easily. 
(Figure 13, 14).  
 
Defects in the tooth enamel was recorded in both participants with junctional 
Epidermolysis bullosa and one person with dystrophic Epidermolysis bullosa, as well as 
excessive occlussal tooth wear (attrition). 
 
The patient with Kindler syndrome (Figures 15,16), presented with erythematous and 
inflamed gingiva, with cratering in the maxillary anterior interdental area. The gingiva 
appeared desquamative, was fragile and bled with even the slightest provocation. Healing 
peri-oral blisters and angular cheilitis was also seen. His mouth opening was restricted 
with a maximal oral aperture of 13mm and his tongue extrusion was limited to only the 
tip of the tongue passing over the lower anterior incisor teeth. 
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Table 9: Recorded oral manifestations in persons with Epidermolysis bullosa 
 JEB 
 
DEB 
 
KINDLER 
SYNDROME 
Oral ulcers/blisters 1 1 ____ 
Atrophy/depapillation 
of dorsal tongue 
surface 
1 1 ____ 
Atrophy of palatal  
mucosa ____ 2 ____ 
Maximal mouth 
opening ____ 13mm 15mm 
Ankyloglossia  1 ____ 
Enamel defects 1 1 ____ 
Occlusal tooth wear 2 2 ____ 
Gingival erythema 
maxillary gingival 
involvement 
extending from 14-
24 
(4mm wide) 
____ ____ 
Spontaneous gingival 
bleeding 1 1 1 
Angular cheilitis ____ ____ 1  
Desquamative 
Gingivitis ____ ____ 1 
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Figure 6 
Moderate plaque accumulation and erythema of the marginal and attached gingiva 
seen in person with Junctional Epidermolysis bullosa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 
Ulcer on soft palate in person with Junctional Epidermolysis bullosa 
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Figure 8 
Depapillation on dorsal tongue surface with healing ulcer 
 
 
 
Figure 9 
Abrasion of maxillary and mandibular posterior teeth 
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Figure 10 
Limited mouth opening of 15mm 
 
 
 
 
 
Figure 11 
Obliteration of palatal rugae 
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Figure 12 
Orthopantomogram showing predominantly root remnants 
 
 
 
Figure 13 
Orthopantomogram of person with Dystrophic Epidermolysis bullosa 
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Figure 14 
Extensive plaque accumulation and moderately inflamed gingival 
 
 
 
Figure 15 
Kindler syndrome – Delicate and reddened (desquamative) attached gingival, 
probably because of the inherent fragility and increased susceptibility to plaque 
induced inflammation. There is also blunting of the interdental papillae 
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Figure 16 
Kindler syndrome – Orthopantomogram 
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7. Dental caries experience 
The dental caries status of the Epidermolysis bullosa and control groups varied according 
to age (Table 10 and 11). 
 
Table 10: dmf values for persons in Epidermolysis bullosa and control groups 
 
Epidermolysis Bullosa 
 n=5 
Control 
n=9 
 
Median 3 2 
# Persons with all 
healthy teeth  
1 3 
Standard Deviation  2.39 5.88 
Minimum 0 0 
Maximum 6 18 
 
Table 11: DMF values for persons in Epidermolysis bullosa and control groups 
Data 
Epidermolysis Bullosa 
n=10 
Control 
n=14 
Count of TOTAL DMF 10 14 
Average of TOTAL 
DMF 15.30 10.14 
# Persons with all 
healthy teeth  1 5 
Standard deviation 10.17 10.88 
Min of TOTAL DMF 0 0 
Max of TOTAL DMF 28 29 
 
 
Although not statistically significant (p>0,1) (due to small sample size), the dmf for 
persons with Epidermolysis bullosa was lower than in the control group  as illustrated by 
the violin plot (Figure 17). All of them had Epidermolysis bullosa Simplex (the mildest 
form). Both dmf distributions for Epidermolysis bullosa and control patients have 
extremely long tails, but the tail of the control group is extreme, with a maximum of 18. 
In the control group 3/9 persons had a dmf of zero compared with 1/5 persons with 
Epidermolysis bullosa. 
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No statistically significant DMF difference was found (Figure 18) between the two 
groups, but the DMF in EB persons (15.3) was generally higher than in the control group 
(10.1), with no significant difference in the total number of teeth present in the adult 
Epidermolysis bullosa persons compared to controls.  
 
No adult persons had a DMF score of 0. In the older children’s group a DMF score of 
zero was calculated in 5/14 control persons compared with 1/10 Epidermolysis bullosa 
persons.  
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Figure 17: Violin plot of dmf in all Epidermolysis bullosa and control participants 
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Figure 18: Violin plot of DMF in all Epidermolysis bullosa and control participants 
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8. Plaque and Gingival index 
There was no statistically significant difference with regard to Plaque index or Gingival 
index between the two groups.  
 
9. Oral impacts on daily performance 
Frequency of oral conditions 
The frequency of perceived oral conditions reported by the participants in the past 6 
months is listed below (Table 12).  
 
As illustrated by Table 12, toothache and tooth decay were the most common complaints 
in both the Epidermolysis bullosa and control participants. The only conditions which 
showed statistical significance between persons with Epidermolysis bullosa and the 
control group were tooth colour, bleeding gums and oral ulceration (p<0.05). 
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Ankyloglossia was seen in 1 person with Epidermolysis bullosa. Limited mouth opening 
(microstomia) was seen in 3 Epidermolysis bullosa persons and oral ulceration was 
reported in 7 Epidermolysis bullosa persons. Due to the small sample, no statistical 
significance was determined. 
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Table 12: Frequency of perceived oral conditions reported by Epidermolysis bullosa 
and control participants 
 EB persons (n=14) Control (n=18) 
16.1 Toothache 10 14 
16.2 Sensitive tooth 4 4 
16.3 Tooth decay/Hole in tooth 11 13 
16.4 Fractured tooth 4 2 
16.5 Tooth loss 2 2 
16.6 Loose tooth 1 0 
16.7 Colour of teeth 4 0 
16.8 Position of teeth 3 2 
16.9 Shape or size of teeth 0 1 
16.10 Bleeding gums 6 2 
16.11 Swollen gums 1 2 
16.12 Other gum diseases 3 1 
16.13 Calculus 3 2 
16.14 Oral ulcer 7 0 
16.15 Bad breath 2 4 
16.16 Deformity of mouth 1 0 
16.17 Noise in jaw joint 0 0 
16.18 Improper filling or crown 0 0 
16.19 Loose denture 2 3 
16.20 Orthodontic appliance 0 0 
16.21 Ankyloglossia/Cannot move tongue 1 0 
16.22 Microstomia/Difficulty in opening mouth 3 0 
16.96 Other — — 
 
10. Oral Impact on Daily Performance (OIDP)  
The reported impacts were centered on daily activities such as eating, speaking and 
sleeping. No calculations were performed to obtain statistical significance between the 
two groups because the sample size did not allow the power to detect any significant 
differences.  
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Figure 19 and 20 shows the percentage distribution of the OIDP scores in the control 
(88.9%) and Epidermolysis bullosa group (85.7%) respectively.  The overall OIDP score 
for both groups was high (87.5%). 
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Figure 19: Stem and Leaf diagram of the OIDP scores in control patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 displays the distribution of the OIDP scores in the control group. This is a long 
tailed distribution with a tail to the larger values.  The median is equal to 9 (the average is 
equal 11.8). The minimum is equal to zero and the maximum is equal to 38.4.  The 
maximum OIDP score of 38.4 influences the dispersion as calculated by the standard 
deviation very much. 
 
Figure 20: Stem and Leaf diagram of the OIDP scores in EB patients 
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Figure 20 displays the distribution of the OIDP scores in the EB group. This is a long 
tailed distribution with a tail to the larger values.  The median is equal to 10.4 (the 
average is equal 11.3).  Comparatively, the tail is shorter compared to that of the control 
group. 
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The prevalence of oral impacts on daily performances in the Epidermolysis Bullosa and 
control groups were calculated by the percentage of participants with OIDP scores more 
than zero.  
 
Table 13: Prevalence of Oral Impacts on Daily Performances in the two groups: 
number of respondents with impacts  
 
 OIDP items Epidermolysis bullosa Control group Total 
1 Eating 12 (85,7%) 16 (88.9%) 28 (87.5%) 
2 Speaking 7 (50.0%) 4 (22.2%) 11(34.4%) 
3 Cleaning teeth 3 (21.4%) 9 (50.0%) 12 (37.5%) 
4 Light activities 0 2 (11.1%) 2 (6.25%) 
5 Vigorous activities 0 2 (11.1%) 2 (6.25%) 
6 Sleeping 8 (57.1%) 8 (44.4%) 16 (50.0%) 
7 Relaxing 2 (14.3%) 4 (22.2%) 6 (18.75%) 
8 Smiling, laughing 5 (35.7%) 10(55.6%) 15 (46.9%) 
9 Emotional state 5 (35.7%) 5 (27.8%) 10 ((31,3%) 
10 Enjoying contact of other people 5 (35.7%) 4 (22.2%) 9 (28.1%) 
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CHAPTER 6: DISCUSSION 
 
Hereditary Epidermolysis bullosa is a rare group of mechanobullous disorders. The rarity 
of the condition made a larger scale study in this population difficult. All studies 
documenting oral findings in persons with Epidermolysis bullosa are descriptive and 
report on an international patient pool (Silva et al, 2004; Pekinar et al, 2005; Azrak et 
al, 2006; Almaani et al, 2008). Two South African studies of Epidermolysis bullosa 
(Menter and Patz, 1975 and Winship, 1986), conducted a nationwide survey to 
delineate the South African Epidermolysis bullosa types and subtypes. To date no South 
African study has described their oral findings, nor reported on how these findings impact 
on their everyday life. 
 
The present study included 14 persons diagnosed with hereditary Epidermolysis bullosa, 
with Epidermolysis bullosa Simplex being the most common.  This is contrary to the 
findings of Winship (1986) who reported dystrophic Epidermolysis bullosa to be the most 
common variant. This discrepancy could be explained by the geographical restriction of 
the sample compared to the nationwide South African pool of persons seen in the study 
conducted by Winship (1986).   
 
Oral manifestations 
Oral findings in persons with Epidermolysis bullosa are widely reported in the 
international literature. Lesion prevalence is expressed according to the Epidermolysis 
bullosa type and subtype, with the Junctional and Dystrophic Epidermolysis bullosa types 
dominating the reports (Almaani et al, 2008). Even though the sample size of our 
Epidermolysis bullosa participants was small (n=14), the oral manifestations seen in the 
present study were consistent with other international case reports (Silva et al, 2004; 
Pekinar et al, 2005; Azrak et al, 2006).   
 
The results of this study reveal no distinctive oral manifestations in the Epidermolysis 
bullosa Simplex type. The absence of oral mucosal lesions in the Epidermolysis bullosa 
Simplex type may be cumulatively due to the more superficial nature of the lesion 
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relative to the other subtypes, as well as the inherently high oral mucosal epithelial 
cellular turnover. This would ensure rapid healing of intra-oral lesions.  
 
In contrast, oral manifestations were more common in persons with recessive Dystrophic 
and Junctional forms of Epidermolysis bullosa, consistent with those described in the 
literature. These included oral ulcerations, atrophy of the tongue and marginal gingival 
erythema. Although earlier case reports have proposed an increased propensity for 
periodontitis in persons with Kindler syndrome (Ricketts 1997), no radiographic 
evidence of bone loss, or periodontal pocket formation was seen in our patient.  
 
Case reports have described “bad teeth, poor, pitted or discoloured enamel” under the 
umbrella term “tooth problems”. Consensus exists that persons with recessive Dystrophic 
and Junctional forms of Epidermolysis bullosa have dysplastic teeth more often than in 
the dominant and Simplex forms of the condition (Gorlin et al, 2007). Both persons with 
Junctional Epidermolysis bullosa and one Dystrophic Epidermolysis bullosa participant 
had dysplastic teeth, pitted enamel and attrition of the occlussal enamel surfaces. The 
other remaining Dystrophic Epidermolysis bullosa participant displayed mostly root 
remnants. A reduced enamel mineral content was reported in severe forms of dystrophic 
Epidermolysis bullosa, but developmental enamel defects were only reported in 8.6% 
(Wright, 1993). Caries is quite prevalent in these persons because of the reduced or poor 
oral hygiene and soft food consumption (Azrak et al, 2006). Our findings are consistent 
with these and reflected by the high dental caries index. 
  
Limited mouth opening was evident in the Dystrophic Epidermolysis bullosa and Kindler 
syndrome patients. Ankyloglossia (in the Dystrophic EB patient) and restricted tongue 
movement in the Kindler patient (limited to tip of the tongue just passing over the lower 
incisor teeth) was consistent with reports in the literature (Chimenos et al, 2003; Wiebe 
et al, 2008). It is generally accepted that mucosal involvement increases over time in 
persons with the more severe types (recessive Dystrophic and Junctional forms of 
Epidermolysis bullosa). Even though our study had no infants or children in these 
categories, reports reveal unremarkable oral mucosa on initial examination of these 
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infants and young children, with no limitations in tongue movement or oral opening. 
With the inevitable dietary transition, an increased exposure to abrasive food textures and 
non-nutritive sucking, results in increased bullae formation. The constant blistering and 
healing results in loss of vestibular sulci, tongue papillae, limitations in tongue movement 
and oral opening. As a result, the dietary intake of liquid and soft foods is increased and 
oral hygiene is made difficult due to the fear of blister formation and the anatomical 
limitations. To this end, poor oral hygiene, caries and moderate plaque accumulations are 
consistently reported. In our study, the children under five years had low dmf scores (in 
both the control and Epidermolysis bullosa groups), which seemingly increased with age, 
a finding that is also common in the general population. In addition to this, the adult 
DMF average and plaque index scores were higher in the Epidermolysis bullosa group, 
despite the high number of persons getting advice from dental health personnel. The high 
plaque scores could perhaps be explained inadequate oral hygiene and the soft diets 
preferred by persons with junctional Epidermolysis bullosa, recessive dystrophic 
Epidermolysis bullosa and Kindler syndrome. Even though they have received advice on 
how to care for their mouths, their dental visits may be restricted to fillings and 
extractions of carious teeth only. 
 
Response to Global general and Dental health questions 
The perceived need (62.5%) for dental treatment was higher than the percentage 
respondents who expressed “poor to fair” dental health (46.9%). In addition to this, the 
adult DMF average and plaque index scores were higher in the Epidermolysis bullosa 
group despite (15.3) despite the high number of persons getting advice from dental health 
personnel. The high plaque scores could perhaps be explained by soft diets preferred by 
persons with junctional Epidermolysis bullosa, recessive dystrophic Epidermolysis 
bullosa and Kindler syndrome. Whilst they have received advice on how to care for their 
mouths, their dental visits may be restricted to fillings and extractions of carious teeth 
only. 
 
Moderate to severe blistering of the skin was seen in the Epidermolysis bullosa group. 
Despite this, all participants in this group perceived their general health as “good, very 
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good and excellent”. Health status and health-related quality of life measures are distinct 
variables and that poor health does not necessarily translate to a poor quality of life. In 
fact, many participants in studies of chronic conditions report their quality of life of is 
good, despite quite severe and clinically obvious physical limitations (Allen, 2003). 
People’s perceptions of oral health vary. Thus, the presence of obvious clinical symptoms 
should not be viewed as a limitation, but as strength, because it allows participants to 
assimilate their various experiences and decide which ones are the most important.  
 
Interviews 
However, data collected via individual face-to-face interviews is time consuming and the 
possibility of respondents being influenced exists, this method ensures personal contact 
and is anticipated to facilitate higher response rates (Katzenellenbogen et al, 1997). In 
addition, the design of the questionnaire was patient centred. This was ensured via a 
literature search of reported oral manifestations as well as pre-survey discussions with 
Epidermolysis bullosa persons with regard to their concerns regarding their oral health.  
The OIDP questionnaire’s format lends itself to ask questions about both beneficial and 
adverse effects on well-being (Slade, 1998). The other advantage is that the answers can 
be evaluated as responses to both individual questions and be summarized as numeric 
scores. 
 
Oral Impacts on Daily Performance (OIDP) Tool 
The OIDP has been validated and reliably used in international population based studies 
in both children and adults. The first South African “exposure” to this tool was validated 
in a pilot project exploring the use of OIDP measure in specific populations with various 
cultural settings. In addition, both children and adults were evaluated together.   A 
questionnaire similar to the one validated in the cross-cultural project mentioned above, 
was used in the present study, which also included children and adults, with an even 
broader range. 
 
In general, the prevalence of oral impacts on the daily performance did not vary 
significantly between the two groups, the only exception being light and vigorous 
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activities. No persons in the Epidermolysis bullosa group attributed any impact of oral 
lesions on these activities. These activities are either avoided due to the nature of their 
condition (blistering following minor trauma); or their “life experience” have made them 
tolerant to any impact thereof. 
 
The present study was designed to encompass objective, quantitative and qualitative 
research measures. Qualitative analysis using an oral health related quality of life 
(OHRQoL) measure such as the oral impact on daily performance (OIDP) tool enabled 
an understanding of the socio-dental impact of perceived oral conditions in everyday life. 
 
Despite the limitations posed by the sample size, the OIDP measure lends insight into the 
consequences of untreated oral soft and hard tissue lesions. It has also linked the most 
common oral problems causing impacts and the priorities of dental health care services. 
Thus, a study was planned with the objective of assessing the prevalence, intensity and 
extent of impacts attributed to mucosal and hard tissue lesions in persons with 
Epidermolysis bullosa, by subtype.  
 
While no precise inferences can be made, trends from this study highlights the need for a 
broader multicentre study using much larger sample sizes and representative persons 
from each EB subtype. The OIDP tool has validated its use as a socio-dental approach to 
needs assessment and planning instrument in dental services. The value of employing 
such a tool has highlighted the need to give more attention to the oral hygiene regimen 
for these persons. It has also provided some insight into consequences of untreated tooth 
decay, as well as the benefit of dental treatment thereof.  
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This enables us to focus our attention on addressing those conditions with the most 
influence on persons with such chronic conditions. 
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 CHAPTER 7: CONCLUSION 
 
The results of the study show that oral lesions (particularly tooth decay and toothache) in 
persons with Epidermolysis bullosa do affect their daily activities and the impact thereof 
is high. Other oral manifestations, irrespective of the subtype, had little impact on the 
OIDP score. This may be because the EB persons have become tolerant of and “learn to 
cope” with them.  
 
Recommendations 
Epidermolysis bullosa is a rare condition and not all persons with EB will present with 
lesions. However, all health personnel (including the dental profession) must be 
cognizant of this condition, in order to manage these persons safely, without incurring 
harm inadvertently. Thus, the overall management of persons with Epidermolysis bullosa 
must encompass ways to minimize and prevent trauma; provide an optimum wound 
healing environment; provide pain management and judicious checks for the 
development of premalignant lesions. This necessitates a multidisciplinary and holistic 
approach, with emphasis on patient involvement. To this end, an oral health care 
programme should form an integral part of their management because of the risk of 
dental disease. Periodic recall visits will enable the monitoring of home care and 
minimize the need for advanced restorative procedures. In this way, one may reduce the 
impact any oral problems may have, so that they do not further influence the patients well 
being.  
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Table 5: Summary of oral findings seen in recessive dystrophic Epidermolysis bullosa and JEB  from  case reports 
Study Summary of extra-oral manifestations Intra-oral lesions 
Pekinar et al, 2005  
Case 1 
Dystrophic recessive EB 
 
 
-12 year old boy with blistering of the hands, ears, knees, elbows, 
feet, trunk, scalp, face, anus. Digital webbing with mitten like 
deformities of the hands were seen and  he experienced  eating 
difficulties related to sever blistering intra-oral 
- White lesions on tongue, gingiva and buccal 
mucosa. 
- Obliteration of palatal rugae and lingual 
papillae  
- Microstomia 
- Rampant caries with poor oral hygiene 
Case 2 - Blisters on the hands, feet, ears, nails, face  -Blisters on palate, lips and tongue 
Silva et al, 2004 
Case 1 
Dystrophic recessive EB 
 
- 8 year old boy with feeding difficulties and limited water intake 
- Digital webbing of hands(mitten-like deformity),  
- nail dystrophy 
- Knees, ears affected 
-  generalized white spot lesions, caries and 
extensive plaque deposits 
- delayed occlussal development 
- blister formation on back of tongue  due to 
trauma from remaining roots 
- ankyloglossia and microstomia 
Case 2 
Dystrophic recessive EB 
-10 year old male with anaemia  and feeding difficulties - white spot lesions, caries, normal tooth eruption 
-had 13 teeth extracted by age 8 years 
Case 3 
Dystrophic recessive EB 
-8 year old female with deformed hands and feet as well as 
anemia 
-microstomia and ankyloglossia 
- Extensive caries with abundant plaque deposits 
- Trauma associated vesicles and ulcers  
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Serrano-Martinez et al, 
2003  
(35 Dystrophic recessive 
EB persons0 
 
 
- Age range of 4-36 years with no reported extra-oral 
manifestations 
-White fibrotic  lesions and blisters on tongue 
-vestibular obliteration, lingual and palatal 
atrophy and milium cysts  
- ankyloglossia and microstomia (All persons) 
Azrak et al, 2006 
Dystrophic recessive EB 
-7 year old boy, with normal mental development, but -retarded 
physical growth 
-generalized blistering present at birth and has mitten- deformity 
of hands 
-had severe anemia at age 5 because of bleeding from eroded 
skin and uses iron tablets sporadically 
- Diet consists of pureed foods and boiled vegetables due to 
development of oesophageal stricture  
-Hyperopia due to corneal opacity ( lacrimal glands unaffected) 
-loss of tongue papillae 
Ankyloglossia and microstomia (30mm) 
Vestibular fundus obliteration 
-poor oral hygiene despite use of power 
toothbrush 
-Orthopantomogram showed normal 
development of teeth 
 
Almaani et al,  2008 
Dominant  JEB 
mutation) 
- 7 year old girl with trauma-induced skin blisters, erosions and 
scars on knees 
- Blisters not present at birth, but arose as a toddler after trauma. 
Blisters waning over past 2 years  
-Abnormal teeth with hypoplastic enamel 
Pacheco and de Sousa 
Araugio, 2008 
Dystrophic recessive EB 
37 year old female finger and nail involvement 
-alopecia 
-constricted larynx 
-trismus 
-poor oral hygiene 
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Table 7: Summary of salient clinical features in major EBS subtypes 
 Autosomal dominant mode of inheritance 
 
Autosomal recessive mode of inheritance 
EBS localized EBS, Dowling-
Meara 
EBS-other 
generalized 
Autosomal 
recessive EBS 
EBS-Ogna EBS-migratory 
circinate 
Onset 
 
Early childhood Birth Birth Birth Birth Birth 
Distribution 
of skin lesions 
 
Palms and soles 
(hands and feet) 
Generalized Generalized 
(scarring) 
Generalized, 
anogenital 
Widespread, 
mostly acral 
Generalized 
Usual skin 
lesions 
Blisters Blisters 
(Herpetiform 
pattern) 
Blisters Blisters blisters Blisters 
Milia 
 
 yes  rare   
Atrophic 
scarring 
 
   Yes   
Dystrophic/ 
absent nails 
 
yes yes yes yes   
Keratoderma 
 
 Diffuse keratoderma Focal 
keratoderma 
   
Oral 
manifestations
 
Intra-oral blisters 
(25%) 
Intra-oral blistering 
common 
Soft tissue lesions 
rare 
   
Eye 
involvement 
Absent Absent Rare    
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Other No tooth 
involvement 
 Exacerbated in 
warm weather 
 Bruising 
tendency 
Post-inflammatory 
brown 
hyperpigmentation 
 
Table 8: Summary of clinical findings in major JEB subtypes 
   
      
ONSET 
 
      
Distribution 
of skin lesions 
 
      
Usual skin 
lesions 
      
Milia 
 
      
Atrophic 
scarring 
 
      
Dystrophic/ 
absent nails 
 
      
Keratoderma       
Oral 
manifestations
 
      
Eye 
involvement 
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Other       
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Table 1:  Inherited Epidermolysis Bullosa Types and Subtypes 
EB Type Inheritance 
Pattern 
EB subtype Target protein (gene) Ultrastructural site of 
epidermal tissue separation 
EBS Autosomal 
dominant 
Suprabasal PKP1 (plakophilin-1) 
DSP (desmoplakin) 
Intra-epidermal, within basal 
keratinocytes 
Autosomal 
recessive –  
(X linked) 
Basal KRT5 (Keratin-5) and KRT14 (Keratin 14) 
PLEC1 (plectin) 
ITGA6, ITGB4 (α6β4 integrin) 
JEB  Herlitz LAMA3, LAMB3, LAMC2 (laminin-332) Within the lamina lucida of 
basement membrane  
Non-Herlitz 
(Other) 
LAMA3, LAMB3, LAMC2, COL17A1 
(TYPE XVII collagen);ITGA6, ITGB4 
(α6β4 integrin) 
DEB Autosomal 
recessive 
Dominant COL7A1 (type VII collagen) Below lamina densa 
Recessive COL7A1 (type VII collagen) 
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Kindler 
Syndrome 
  KIND1 (kindling-1) Mixed cleavage plane 
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Bilingual Interviewer Administered Questionnaire – 2008/9 
 
 1
PREVALENCE AND IMPACT OF ORAL LESIONS ON QUALITY  
OF LIFE IN EB - OIDP Study 
Interviewer Administered Oral Health Survey Questionnaire  
 
Introduction: 
This interview is about your health, about mouth and teeth problems and about dental treatment. There is no 
right or wrong answer. Please feel free to ask about anything you don't understand. 
 
1) Study Record Number 
 
   
  
2) Date D M 200 
 
3) Geslag /Sex Male Female 
 
4) Hoe oud is jy? (jare)//Age in years 12  16    
 
5) Geographic location (CIRCLE ONE) 1 = Urban 2 = Rural/small town 
 
6a) Occupation  
 
6b) Type of EB (CIRCLE ONE) 1 = EBS  2 = JEB 3= DEB 
    
General Health Questions 
Now, I am going to ask you some broad questions about your general and dental health: 
Nou gaan ek ‘n paar vrae oor jou algemene gesondheid vra: 
 
7) In general would you say your health is//My algemene gesondheid is: 
1_______________2_______________3_______________4_______________5 
       Very Poor                   Poor                         Fair               Good                 Very good 
       Baie sleg     Sleg       Aanvaarbaar  Goed     Baie goed 
 
8) In general would you say your dental health is// My tandheelkundige gesondheid is 
1_______________2_______________3_______________4_______________5 
       Very Poor                   Poor                         Fair               Good                 Very good 
       Baie sleg     Sleg       Aanvaarbaar  Goed     Baie goed 
 
9) How satisfied are you with your oral health? Hoe tevrede is u met jou tandheelkundige gesondheid? 
1_______________2_______________3_______________4_______________5 
       Not at all         Very satisfied  
      Baie ontevrede               Heeltemaal tevrede 
 
10) How much do you think you need dental treatment? Hoeveel benodig jy tandheelkundige behandeling? 
1_______________2_______________3_______________4_______________5 
       Not at all         A great deal 
       Heeltemaal onnodig       Erg nodig 
 
11) Have you ever received advice on how to care for the health of your mouth?      1 =Yes 2 = No
      Het jy ooit  advies gekry hoe om jou mond gesond te hou?  (Skip to 13) 
 
 
 
 
Bilingual Interviewer Administered Questionnaire – 2008/9 
 
 2
     
12)  If yes, from where did you get this information? (READ CATEGORIES CODE ALL THAT APPLY)  
      As jy ja beantwoord het, se asseblief waar jy die informasie gekry het? 
    
Family/Friends // Familie of vriende 1 
School // Skool 2 
TV / radio 3 
Dental/Health Personnel // Tandheelkundige  personeel 4 
Newspapers or Magazines // Koerante of tydskrifte 5 
Other//Ander bronne (Specifiy//Wees specifiek) 96 
Specify…  
 
OIDP Assessment 
Now I would like to ask you if problems with your mouth, teeth or dentures have caused you difficulty 
with any everyday activities in the past 6 months. 
Nou wil ek jou vra oor die uitwerking van enige tandheelkundige probleme op jou daaglikse lewe 
gedurende die laaste ses maande. 
 
(INSERT ANSWERS to QUESTIONS 13-16 IN THE OIDP ASSESSMENT Chart ON NEXT PAGE). 
 
13)  In the past six months, have you had any of the problems mentioned in the OIDP Chart below.   
       Gedurende die laaste ses maande, het jy enige van die volgende probleme ontvaar?  
 
(CIRCLE EITHER “Y” OR “N” IN THE OIDP CHART) 
 (If answer is Yes, GO TO QUESTIONS 14-16 WITH THIS DIMENSION) 
 (If answer is No REPEAT QUESTION 13 WITH NEXT DIMENSION) 
 
14)  During the past six months how often have you had this problem (INSERT DIMENSION)? 
       Gedurende die laaste ses maande, hoe gereeld het jy hierdie probleem  ervaar? 
 
(READ ANSWERS AND CODE IN THE OIDP ASSESSMENT CHART)  
Minder as een keer per maand//Less than once a month 1 
Een tot twee keer per maand//Once or twice a month 2 
Een tot twee keer per week//Once or twice a week 3 
Drie tot vier keer per week//Three to four times a week 4 
Amper elke dag//Every, or nearly every, day 5 
 
15)  Using a scale from 0 to 5, where 0 is no effect and 5 is a very severe effect, which number would 
you say reflects the effect this problem had on your daily life? 
Hoe sou jy hierdie probleem op ‘n skaal van nil tot vyf tel, as nil beteken geen uitwerking en vyf 
beteken ‘n enorme uitwerking? 
 
(CODE ACCORDINGLY IN THE OIDP ASSESSMENT CHART) 
   
0             1               2                3                  4                    5 
          No effect                                                                                           Very severe effect 
 Geen  uitwerking      Enorme uitwerking 
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 3
16)  To which condition(s) do you attribute this impact? 
        Aan watter rede(s) sou jy hierdie uitwerking toeskryf? 
       
(READ CATEGORIES, CODE ALL THAT APPLY) 
  
Different conditions Code 
Tandpyn//Toothache  1 
Sensitiewe tande//Sensitive tooth  2 
Tandbederf, ‘n gat in jou tand//Tooth decay, hole in a tooth  3 
Gebreuke tand//Fractured tooth  4 
Verlies van ‘n tand(e)//Tooth loss  5 
Los tand(e)//Loose tooth. 6 
Gekleur van tande//Colour of teeth  7 
Rangskikking van jou tande//Position of teeth (crooked, gap) 8 
Vorm of grootte van tande//Shape or size of teeth  9 
Tandvleis wat bloei//Bleeding gums  10 
Opgeswelde tandvleis of absess //Swollen gums, gum abscess  11 
Ander tandvleis siektes//Receding gums, gum disease, pyorrhoea  12 
Tartar of graweel// Calculus,  13 
Mondsweer//Oral ulcer or sore spot  14 
Stink asem//Bad breath  15 
Mondmismaaktheid//Deformity of mouth or face (cleft lip, cleft palate) 16 
Snaakse geluide by kakabeen lit//Clicking or grating noise in jaw joint  17 
Tandstopsel verkeerde kleur of afgebreek//Improper filling or crown  18 
Tandstelsel los//Loose ill fitting denture or plate  19 
Ortodontiese stel//Orthodontic appliance, wires or bands  20 
Ander rede//Other (SPECIFY//Wees spesifiek)  96 
 
OIDP Assessment Chart 
 
 
Dimensions 
Questions 
 
As jy…..//When you are… 
13 
Y/N
14 
Frequency 
15 
Severity 
16 
Condition 
Kos eet//Eating Food Y/N    
Suiwer wil praat//Speaking clearly Y/N    
Tande skoonmaak//Cleaning your teeth/dentures Y/N    
Huishoudelike werk//Doing light activities such as household 
cleaning and maintenance, working on a car, playing games 
 
Y/N
   
Kragtige aktiwiteit//Vigorous activities such as running, 
lifting heavy objects, strenuous sports 
Y/N    
Slaap//Sleeping Y/N    
Ontspan//Relaxing - reading, watching TV, listening to music Y/N    
Glimlag of lag//Smiling, laughing and showing teeth without 
embarrassment 
Y/N    
Dit laat my meer emosieneel voel//With your emotional state, 
for example, becoming more easily upset than usual 
Y/N    
Gemaklikheid by vriende and familie//Enjoying the contact of 
other people, such as relatives, friends or neighbors 
Y/N    
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 4
Gesondheid aktiwiteite//Health Behaviours 
Now, I would like us to focus on some basic behaviours that are related to health. 
Nou wil ons oor sekere gesondheids aktiwiteite praat. 
 
17)      Did you clean your teeth yesterday? 1 =Yes 2 = No  
           Het jy jou tande gister skoongemaak?  (Skip to 20) 
 
18) How many times did you clean your teeth yesterday? 
Hooeveel keer het jy jou tande gister skoongemaak? 
(READ ANSWERS) 
Eenkeer//Once 1 
Tweekeer//Twice 2 
Meer//More than twice 3 
 
19) Which of the following items did you use to clean your teeth? 
Wat het jy gebruik om jou tande skoon te maak 
(READ ANSWERS, CODE ALL THAT APPLY)  
 
 
 
 
SPECIFY …….. 
Toothbrush/Borsel 1 
Chewing stick/stok 2 
Finger/Vinger 3 
Fluoride toothpaste 4 
Floss 5 
Toothpick 6 
Mouthrinse/Spoel 7 
Other...SPECIFY 96 
 
 
 
 
 
UNIVERSITY OF THE WESTERN CAPE 
 
FACULTY OF DENTISTRY 
 
INFORMED CONSENT FOR ORAL EXAMINATION 
 
 
Dear ................................................................. 
 
I am from the Department of Oral Medicine and Periodontology at the University of the Western 
Cape Dental Faculty. I would like to ask you some questions about yourself, examine your mouth 
and teeth to look for any problems. This is part a research project to see if you have any oral 
problems and assess how we can prevent and help you with these problems. 
 
The procedure will take about 10-15 minutes. There are no risks in participating, with no more 
discomfort than in a routine dental check up examination. All information gathered in the study will 
be treated as strictly confidential. No one will have access to this information except the researcher. 
If you agree, photographs of oral problems will be taken stored in such a way as to keep it as 
confidential as possible.  
 
You are completely free to take part or not to take part in the study. If you decide that you do not 
want to be part of the study, this will not be held against you. 
 
If you are willing to take part in the study, please sign the form below to allow us to proceed with 
the examination. If you would like to withdraw from the study at any point or for any reason, please 
feel free to do so and no questions will be asked. 
 
If you have any questions or queries or would like more information about the study please contact  
Dr Haly Holmes on telephone number (021) 937 3167/8 ; fax (021) 931 2287; e-mail 
hholmes@uwc.ac.za or 0832311633. 
 
Thank you for your cooperation 
 
Yours sincerely 
 
 
 
Dr Haly Holmes 
-------------------------------------------------------------------------------------------------------------- 
I have understood the instructions and information given to me and I agree to participate in the 
study. I have not been forced to participate in the above-mentioned study. 
 
 
Name: ...............................................                                 ................................................ 
(in block letters)       
 (Signature/Parent/Guardian) 
 
Date:     ............................................... 
 
 
 
 
 
 
 
 
UNIVERSITEIT WES-KAAPLAND 
 
FAKULTEIT TANDHEELKUNDE 
 
TOESTEMMINGSVORM VIR MOND ONDERSOEK 
 
 
Geagte …………………………………………………………………. 
 
Ons is van die Departement Gemeenskapstandheelkunde, Universiteit Wes-Kaapland.  Ons wil u 
graag ‘n paar vrae vra omtrent uself en u mond en tande ondersoek om vas te stel of daar enige 
probleme is.  Dit is deel van ‘n navorsings project en  ons doen hierdie ondersoek om vas te stel hoe 
ons probleme met u mond en tande kan voorkom, en as daar reeds probleme is, u daarmee te help. 
 
Die ondersoek neem ongeveer 10-15 minute. Daar is geen risikos aan deelname nie en die ongemak 
wat u sal verduur sal soortgelyk aan ‘n roetine tand- en mondondersoek wees.  Alle inligting 
versamel sal streng vertroulik hanteer word.  Niemand behalwe die navorser sal toegang tot die 
inligting hê nie.  U naam of enige inligting wat u mag identifiseer sal in die verslae van hierdie 
studie gebruik word nie.  Alle inligting versamel sal so konfidensieel moontlik geberg word. 
 
Inligting wat u omtrent uself verskaf is ook streng vertroulik.  Dit is u eie keuse of u wil deelneem 
aan hierdie studie. Daar sal geensins teen u gediskrimineer word indien u deelneem of nie deelneem 
nie. 
 
Indien u bereid is om deel te neem aan hierdie studie, teken asseblief die onderstaande vorm om ons 
toe te laat om voort te gaan met die ondersoek.  Indien u op enige stadium van die ondersoek en 
studie wil onttrek is u nie gebind nie en geen vrae sal gevra word nie. 
 
Enige vrae en navrae, of indien u meer inligting verlang skakel asseblief met Prof Neil Myburgh by 
telefoon nommer (021) 937 3150; faks (021) 931 2287; e-pos nmyburgh@uwc.ac.za of na-ure by 
(021) 6833395. 
 
Dankie vir u samewerking 
 
 
Professor Neil Myburgh 
Ek verstaan die inligting en gee hiermee my toestemming om deel te neem aan die studie.  Ek was 
onder geen verpligting geplaas om deel te neem aan bogenoemde studie nie. 
 
 
Naam:……………………………………        Handtekening:………………………(Ouer,gesinslid) 
(in drukskrif) 
 
Getuie: ………………………………………….. 
 
 
Datum: …………………………………………. 
 
 
 
 
 
 
